Nuvalent

About:

Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.

Website: https://www.nuvalent.com

Twitter/X: nuvalent

Top Investors: Fidelity, Deerfield, Wellington Management, Bain Capital Life Sciences, Viking Global Investors

Description:

Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. It is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.